@RickOrford
YouTube
Avg. Quality
69
Success Rate
21.86
Analysis
366
Correct
80
Fail
198
Pending
88
Ineffective
0
Total Quality
Score
If You Had Traded on This Analysis…
Fail
LLY
Long Entry
1,023.2600
2026-02-20
00:00 UTC
Target
1,200.0000
Fail
950.0000
In 4 Weeks
Risk/Reward
1 : 2
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Final PnL
-7.16%
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The analysis focuses on Eli Lilly (LLY) and its potential for a significant breakout. The stock has shown strong performance, exceeding $1000 per share. The speaker plans to break down the company's financials, growth drivers, and valuation for 2026. Key points include a potential revenue jump from $65 billion to over $80 billion in one year, a $2.4 billion acquisition, and the ongoing growth in drug sales. The core question is whether the market is underestimating the pipeline and if the current valuation makes sense for 2026. If expectations are already priced in, the risk could be significant.
